is there hope for treating tp53-mutated mds?
Published 5 years ago • 1.2K plays • Length 1:06Download video MP4
Download video MP3
Similar videos
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
1:43
reasons why there are fewer treatment options for mds patients and hope for the future
-
2:23
improving treatment for patients with tp53-mutated myeloid malignancies
-
0:58
options available to patients with tp53-mutated mds beyond stem cell transplantation
-
2:24
the challenges of treating tp53-mutated aml and mds
-
3:39
the association between prior exposure to lenalidomide and tp53-mutated aml/mds
-
1:26
updates in the treatment landscape of p53-mutated aml/mds
-
3:22
is tp53-mutated high-risk mds the same disease as tp53-mutated aml?
-
2:43
magrolimab azacitidine in tp53-mutant aml
-
7:11
treatment of older mds patients with bmt (bone marrow transplantation)
-
3:08
recent updates on tp53 mutation in cll
-
3:00
apr-246 in tp53 mutated mds and aml
-
4:31
the impact of high and low burden tp53 mutations on risk and treatment decision in cll
-
5:16
an analysis of tp53 mutation in aml and hr-mds
-
1:53
challenges in treating patients with tp53-mutated aml and future outlooks
-
1:23
immunological impact of tp53 in mds
-
1:27
treatment options for patients with tp53-mutated aml
-
2:42
challenges in treating patients with tp53-mutated mcl & promising novel therapies being explored
-
1:13
the challenges of treating patients with mpns who possess a tp53 mutation
-
0:46
the prognostic impact of tp53 mutation in mpns
-
1:25
should patients with tp53-mutated mds receive stem cell transplant?
-
1:21
identifying low-burden tp53 mutations with ngs in cll